Episode 3.4 Ovarian and Endometrial Cancers, Endometrial Ablation, and COVID

In this episode, we discuss reasons for the falling rates of ovarian cancers and the rising rates of endometrial cancers. We also discuss the impact that endometrial ablation may have on worsening endometrial cancer outcomes in light of other alternatives to hysterectomy, such as IUDs. Finally, we discuss some COVID updates including whether or not pregnant women with COVID should receive anticoagulation. 

Links Discussed:


The Changing Landscape of Gynecologic Cancer Mortality in the United States

Ovarian Cancer Statistics, 2018

Uterine Cancer Incidence and Mortality — United States, 1999–2016

It’s easy to become obese in America. These 7 charts explain why.

The effect of diabetes on the risk of endometrial Cancer: an updated a systematic review and meta-analysis

Risk factors for endometrial cancer: An umbrella review of the literature

Losing Weight Linked to Lower Risk of Uterine Cancer

Metformin Associates With Aggressive Features of Endometrial Cancer in Women With Type 2 Diabetes

The case against endometrial ablation for treatment of heavy menstrual bleeding

Management of Abnormal Uterine Bleeding with Emphasis on Alternatives to Hysterectomy

A critical review of the pathophysiology of thrombotic complications and clinical practice recommendations for thromboprophylaxis in pregnant patients with COVID-19

Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery